NCT06844006 Investigating the Impact of Nudging Cardiologists to Prescribe Guideline-directed Medical Therapy in Heart Failure Patients
| NCT ID | NCT06844006 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Medisch Spectrum Twente |
| Condition | Heart Failure |
| Study Type | INTERVENTIONAL |
| Enrollment | 1,320 participants |
| Start Date | 2024-06-13 |
| Primary Completion | 2027-04-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 1,320 participants in total. It began in 2024-06-13 with a primary completion date of 2027-04-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study investigates the impact of a nudge-based intervention on improving guideline directed medical therapy (GDMT) prescription among cardiologists. Using a stepped wedge randomized controlled trial design, we assess whether digital decision support-leveraging home monitoring and clinical data-enhances adherence to guideline-recommended medication titration. The primary outcomes include HF related hospitalization rates and all cause mortality.
Eligibility Criteria
Inclusion Criteria: * All heart failure diagnoses * \>18 years Exclusion Criteria: * Not understanding the Dutch Language. * Allergies that make uptitration impossible. * Admission to hospice or palliative care. * Severe psychological disorders.
Frequently Asked Questions
Who can join the NCT06844006 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Heart Failure. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06844006 currently recruiting?
Yes, NCT06844006 is actively recruiting participants. Visit ClinicalTrials.gov or contact Medisch Spectrum Twente to inquire about joining.
Where is the NCT06844006 trial being conducted?
This trial is being conducted at Enschede, Netherlands.
Who is sponsoring the NCT06844006 clinical trial?
NCT06844006 is sponsored by Medisch Spectrum Twente. The trial plans to enroll 1,320 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.